Diabetes Conference First Day Highlights


Diabetes Update #2 Day 1, Friday June 10 from the American Diabetes Association National Meeting

Dr. Ruchi Mathur offers perspectives of interest on topics from the American Diabetes Association's 65th Annual Scientific Sessions (held in San Diego, California June 10-14, 2005)

Medical Podcast

Listen now to Day 1 Highlights from Dr. Ruchi Mathur who is at the diabetes conference in San Diego  (MP3 2:26min 2.23MB)

Hello! This is Dr. Ruchi Mathur updating you from San Diego California where today, Friday June 10, marked the opening of the American Diabetes Association's 65th Scientific Symposia. As expected, the turnout of participants is outstanding and the quality of lectures and discussions is top notch.

While there are many topics being discussed, I've chosen a few highlights from today's schedule to share with you.

One of the first symposia presented today was on the role of obesity and how it contributes to the inflammatory processes that can lead to heart disease. The presenter noted a significant increase in the markers of inflammation we can measure clinically (such as C-reactive protein and Interleukins) in subjects who are obese. Interestingly, If the fat is located around the abdomen (central obesity) - the inflammatory markers increase further. The presenter made an interesting comment stating that perhaps we should start thinking of fat as a hormonal tumor capable of contributing to the development of hypertension and diabetes that accompanies obesity.

In another session, the topic focused on insulin pump therapy. Usually when we think of insulin pumps , we think of it as a therapy for type 1 diabetes. Over 250,000 patients use insulin pumps, and actually about 30,000 of these patients have type 2 diabetes. The presenter reviewed the data on blood glucose control in patients with type 2 diabetes receiving shots versus pump therapy. In summary, in these controlled trials, there was no significant difference in A1c, or hypoglycemia. However, those on the pump reported an increase in quality of life measures. What does this mean? Basically, with a good relationship between patient and physician, either method is able to work. However, insulin pump therapy may provide more freedom and increased quality of life on a daily basis. If you have questions about insulin pump therapy and you have type 1 or type 2 diabetes, don't hesitate to discuss this option with your physician. The newer, smarter insulin pumps on the market are raising the bar in ease of usage and reliability.

In the next installment, I will update you on a new drug just on the market that has a strange link to reptiles. Stay Tuned.

Check back on our Diabetes center for the daily updates!

Return to Update Index

Subscribe to MedicineNet.com's Diabetes Newsletter.

Free Newsletter
Diabetes Newsletter